> Skip repeated content
photo of Lila R. Baaklini, MD

Lila R. Baaklini, MD

phone icon

About Dr. Baaklini

Dr. Lila R. Baaklini is a board certified anesthesiologist, who completed her residency at Yale-New Haven Medical Center, where she served as chief resident in her final year. Upon completing her residency, she spent one year as an HSS Regional Anesthesiology and Acute Pain Medicine fellow.


Patient Stories


If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.



Assistant Attending Anesthesiologist, Hospital for Special Surgery
Clinical Instructor in Anesthesiology, Weill Cornell Medical College


Diplomate American Board of Anesthesiology, 2016


Chief Resident, Yale-New Haven Medical Center 2014-2015


Rutgers, New Jersey Medical School, Newark, NJ, 2011


Rutgers, New Jersey Medical School, Newark, NJ, 2012


Yale, New Haven Medical Center, New Haven, CT, 2015


Regional Anesthesia and Acute Pain Medicine, Hospital for Special Surgery, 2015-2016

State Licensure



For My Patients

Publications by Dr. Baaklini


Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of May 11, 2024, Dr. Baaklini reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.